Storage Appliance gains $3m from Intel Capital.
Month: January 2011
OSI spies EyeGate potential
EyeGate Pharmaceuticals extends D round to $28.5m.
GM Ventures agrees first international deal
As part of its $5m investment, GM Ventures has agreed exclusivity on the use of Powermat products in its cars for the first year and is expected to have them in its electric Chevrolet Volt vehicle by next year.
LinkedIn preps flotation
Newswire Reuters said a prospectus for LinkedIn’s initial public offering was expected to be completed by end-March with the three banks as book-runners selling its shares to the public.
Symphogen for Europe’s largest drugs round
Novo, a $20bn quasi-corporate venturing investment company wholly owned by the Novo Nordisk Foundation, is leading a $130m round for Symphogen.
London Investment Conference on 10 February 2011
Free to attend by invitation to the University of Chicago Booth School of Business-hosted investment conference and reception in London, UK.
Square eyes new investment peg
News provider Techcrunch says Square is looking to raise $200m.
Quest ends search for Symplified
Venture capital firms Granite Ventures and Allegis Capital also reinvested in Symplified’s latest round, which has taken its total total funding to $18.8m including new backing from Nasdaq-listed Quest Software.
Satori finds $7m in enlightenment
Satori Pharmaceuticals raises $7m.
Jiangsu Broadcasting finds Joy.cn
Venture capital firm Huashang Yingtong also participated in the A round for Joy.cn along with media group Jiangsu Broadcasting.
Hearst joins Google in Miso’s band
Google Ventures leads the $1.5m series A round for Miso, having the month before invested in the portfolio company’s $600,000 seed round.
Shire steps into DBV’s C round
InnoBio Fund and Lundbeckfond Ventures lead $25.5m round for DBV Technologies, which includes Shire.
Qteros sees its way to initial $22m
Qteros, formerly known as SunEthanol, nearly doubles its $25m B round with $22m initial close of its series C.
GSK and Genzyme invest in Longwood fund
Longwood Founders Management raises $85m for its first fund with GlaxoSmithKline and Genzyme among its limited partners.